i-Optics BV:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:i-Optics BV - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7223
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
I-Optics BV (I-Optics) is a medical device company that manufactures and distributes optical devices. The company offers Cassini, a corneal shape analyzer that measures the axis and magnitude of corneal astigmatism and EasyScan, a zero-dilation retinal imaging system to diagnose retinal diseases including diabetic retinopathy, age-related macular degeneration, and glaucoma. I-Optics’ Cassini product offers a suite of examinations required for toric and multifocal IOL implantation, which includes corneal topography, mesopic, photopic pupillometry and color photography for diagnostic purpose. The company offers solutions such as retina and cornea imaging and eye diagnosis solutions. It sells products through a network of distributors in Switzerland, Italy, Spain, the Netherlands, France and Belgium. I-Optics is headquartered in the Hague, the Netherlands.

i-Optics BV – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
i-Optics BV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
i-Optics BV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
i-Optics BV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
i-Optics BV, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
i-Optics BV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
i-Optics BV, Medical Equipment, Deal Details 10
Venture Financing 10
i-Optics Raises US$15 Million In Series D Financing 10
Partnerships 12
Hoya Vision Care Enters into Distribution Agreement with i-Optics 12
TrueVision Systems and i-Optics Enter into Partnership 13
Debt Offering 14
i-Optics Raises USD10.8 Million in Private Placement of Debt Financing 14
i-Optics BV – Key Competitors 15
i-Optics BV – Key Employees 16
i-Optics BV – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Product News 18
Oct 04, 2017: Record 12 clinical studies on improving cataract surgery outcomes with Cassini to be presented during ESCRS 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
i-Optics BV, Medical Equipment, Key Facts 2
i-Optics BV, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
i-Optics BV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
i-Optics BV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
i-Optics BV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
i-Optics BV, Deals By Market, 2012 to YTD 2018 8
i-Optics BV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
i-Optics Raises US$15 Million In Series D Financing 10
Hoya Vision Care Enters into Distribution Agreement with i-Optics 12
TrueVision Systems and i-Optics Enter into Partnership 13
i-Optics Raises USD10.8 Million in Private Placement of Debt Financing 14
i-Optics BV, Key Competitors 15
i-Optics BV, Key Employees 16

List of Figures
i-Optics BV, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
i-Optics BV, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
i-Optics BV, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
i-Optics BV, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
i-Optics BV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
i-Optics BV, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
i-Optics BV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
i-Optics BV, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[i-Optics BV:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Votorantim Energia Ltda.:企業の戦略的SWOT分析
    Votorantim Energia Ltda. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Great Basin Scientific Inc (GBSN):製品パイプライン分析
    Summary Great Basin Scientific Inc (Great Basin) is a molecular diagnostics company that offers technology products. The company develops and distributes point-of-care technology and products to improve automation, throughput, scalability, reliability and ease-of-use in rapid diagnostic testing. It …
  • Essar Steel Ltd:企業の戦略・SWOT・財務情報
    Essar Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary Essar Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Virtusa Corp (VRTU):企業の財務・戦略的SWOT分析
    Virtusa Corp (VRTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Crescita Therapeutics Inc (CTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) is a commercial dermatology company that offers prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. The company’s products comprise Pliaglis, Alyria, Laboratoire Dr Renaud, Pro-Derm, Premi …
  • BHG SA – Brazil Hospitality Group:企業の戦略・SWOT・財務情報
    BHG SA - Brazil Hospitality Group - Strategy, SWOT and Corporate Finance Report Summary BHG SA - Brazil Hospitality Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • VidaCaixa, S.A.U. de Seguros y Reaseguros:企業の戦略・SWOT・財務情報
    VidaCaixa, S.A.U. de Seguros y Reaseguros - Strategy, SWOT and Corporate Finance Report Summary VidaCaixa, S.A.U. de Seguros y Reaseguros - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • ThermoGenesis Holdings Inc (THMO):企業の財務・戦略的SWOT分析
    ThermoGenesis Holdings Inc (THMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Escalon Medical Corp (ESMC)-医療機器分野:企業M&A・提携分析
    Summary Escalon Medical Corp (Escalon) is a medical device company with focus on ophthalmology. It carries out the development and sale of ophthalmic medical devices. Its major products include A-Scan and B-Scan diagnostic tools, UBM high frequency/high resolution ultrasound devices, pachymeters, co …
  • Macronix International Co Ltd (2337):企業の財務・戦略的SWOT分析
    Macronix International Co Ltd (2337) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Rousselot S.A.S.:企業の戦略・SWOT・財務情報
    Rousselot S.A.S. - Strategy, SWOT and Corporate Finance Report Summary Rousselot S.A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Midatech Pharma Plc (MTPH):企業の財務・戦略的SWOT分析
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimm …
  • Merrimack Pharmaceuticals Inc (MACK):企業の財務・戦略的SWOT分析
    Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Unipol Gruppo Finanziario S.p.A.:戦略・SWOT・企業財務分析
    Unipol Gruppo Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Unipol Gruppo Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Nisshinbo Holdings Inc. (3105):企業の財務・戦略的SWOT分析
    Nisshinbo Holdings Inc. (3105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Endeavor Energy Resources LP:石油・ガス:M&Aディール及び事業提携情報
    Summary Endeavor Energy Resources LP (Endeavor Energy) is an independent oil and gas company that acquires, explores, develops and produces crude oil and natural gas properties. The company has operations in the Delaware Basin which offers horizontal and vertical drilling in Winkler, Ward, Loving, R …
  • TxCell SA (TXCL):企業の財務・戦略的SWOT分析
    Summary Txcell SA (Txcell) a subsidiary of Sangamo Therapeutics Inc, is a biotechnology company that develops personalized cellular immunotherapies using regulatory T cells (Treg) for the treatment of autoimmune and inflammatory diseases as well as transplantation-related inflammatory disorders. The …
  • Advance Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Advance Pharmaceutical Co Ltd (APC), formerly Dang Ling is a healthcare products provider that manufactures and distributes prescription and over the counter pharmaceutical products. The company’s products include vitamins and supplements, cough syrups, skin care, disinfectant liquids, and r …
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development-製薬・医療分野:企業M&A・提携分析
    Summary Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the …
  • Compagnie Generale des Etablissements Michelin:企業の戦略・SWOT・財務分析
    Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report Summary Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆